Literature DB >> 16093777

Endoscopic palliation of pancreatic adenocarcinoma.

Wichit Srikureja1, Kenneth J Chang.   

Abstract

PURPOSE OF REVIEW: Endoscopic therapies have become an indispensable modality in the treatment and palliation of complications from pancreatic adenocarcinoma. This review focuses on treatment of biliary obstruction, malignant gastric outlet obstruction, and intractable abdominal pain resulting from unresectable pancreatic adenocarcinoma. Novel and emerging endoscopic approaches are also briefly discussed. RECENT
FINDINGS: Endoscopic placement of a biliary stent is the modality of choice for palliation of biliary obstruction. Biliary self-expanding metal stents should be placed if expected survival is more than 6 months and plastic stents if expected survival is less than 6 months. For endoscopic palliation of gastric outlet obstruction, enteral self-expanding metal stents should be placed. Biliary self-expanding metal stents should be considered prior to the placement of a duodenal stent. Palliation of intractable abdominal pain can safely be performed with endoscopic ultrasound-guided celiac plexus neurolysis using bupivacaine and absolute alcohol. Exciting novel endoscopic approaches are being evaluated especially in the area of drug-eluted biliary stents, endoscopic creations of enteral anastomoses, and endoscopic ultrasound-guided injection of gene vectors.
SUMMARY: The frontier of endoscopic palliative therapies for pancreatic adenocarcinoma is expanding. Clinical trials are needed to evaluate novel endoscopic approaches.

Entities:  

Mesh:

Year:  2005        PMID: 16093777     DOI: 10.1097/01.mog.0000172750.05280.02

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  6 in total

1.  Unresectable pancreatic adenocarcinoma: do we know who survives?

Authors:  Mohammad H Jamal; Suhail A Doi; Eve Simoneau; Jad Abou Khalil; Mazen Hassanain; Prosanto Chaudhury; Jean Tchervenkov; Peter Metrakos; Jeffrey S Barkun
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

2.  McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.

Authors:  Mohammed H Jamal; Suhail A R Doi; A James Moser; Sinziana Dumitra; Jad abou Khalil; Eve Simoneau; Prosanto Chaudhury; Adedayo A Onitilo; Peter Metrakos; Jeffrey S Barkun
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Trimming of a Broken Migrated Biliary Metal Stent with the Nd:YAG Laser.

Authors:  I Zuber-Jerger; F Kullmann
Journal:  Case Rep Gastroenterol       Date:  2009-03-28

4.  Endoscopic palliation for pancreatic cancer.

Authors:  Mihir Bakhru; Bezawit Tekola; Michel Kahaleh
Journal:  Cancers (Basel)       Date:  2011-04-13       Impact factor: 6.639

5.  Radiotherapy prolongs biliary metal stent patency in malignant pancreatobiliary obstructions.

Authors:  Semi Park; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Jae Bock Chung; Si Young Song
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

6.  Combined Intestinal and Biliary Stenting in Gastric Outlet and Biliary Obstruction.

Authors:  Guang Chuan Wang; Feng Liu; Tian Hua Xie; Fu Li Liu; Chun Qing Zhang
Journal:  Gastroenterology Res       Date:  2009-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.